Home › Trials › NCT03296202

Monitoring health risks in people living with HIV on antiretroviral treatment

Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV: The ANRS CO3 Aquitaine Cohort - AquiVIH-NA

Observational University Hospital, Bordeaux · NCT03296202

This study looks at the long-term health effects of antiretroviral treatment in people living with HIV to see how their overall health and well-being change over time.

Quick facts

Study typeObservational
Enrollment7200 (estimated)
Ages18 Years and up
SexAll
SponsorUniversity Hospital, Bordeaux Academic / other
Locations24 sites (Agen and 23 other locations)
Trial IDNCT03296202 on ClinicalTrials.gov

What this trial studies

This observational cohort study aims to monitor the long-term health outcomes of individuals living with HIV who are receiving antiretroviral therapy (ART). It focuses on understanding the evolution of morbidities, complications, and side effects associated with ART over time. Data will be collected through standardized questionnaires during hospital visits, capturing demographic, clinical, biological, and therapeutic information. The study also emphasizes the importance of evaluating both biomedical and psychosocial factors affecting the health of people living with HIV.

Who should consider this trial

Good fit: Ideal candidates for this study are adults over 18 years old with a confirmed HIV infection who can provide informed consent.

Not a fit: Patients with HIV-2 infection will not benefit from this study as they are excluded from participation.

Why it matters

Potential benefit: If successful, this study could lead to improved management and treatment strategies for individuals living with HIV, enhancing their quality of life.

How similar studies have performed: Other studies have shown success in monitoring long-term outcomes in HIV populations, making this approach both relevant and necessary.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Patients aged over 18 years old.
* Confirmed HIV infection
* Signed informed consent

Exclusion Criteria:

* HIV-2 infection

Where this trial is running

Agen and 23 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov → Find more trials like this →
Conditions HIV InfectionsAntiretroviral AgentsHIVcohort studiesantiretroviral treatment
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.